Dipen Desai

This inventor holds 51 USPTO granted patents and 24 published patent applications, plus 10 CIPO patents and 13 EPO patents, primarily in Drug Delivery Systems. Top assignees: Amneal Complex Products Research LLC, Kashiv Biosciences, LLC, Kashiv Specialty Pharmaceuticals, LLC. Active years: 2012-2026.

USPTO Granted Patents = 51 (Patent Applications = 24)

% Patents Active = 96.1

CIPO Patents = 10 (Patent Applications = 7)

EPO Patents = 13 (Patent Applications = 20)

Average Co-Inventor Count = 5.5

ph-index = 5

Forward Citations = 152(Granted Patents)

Forward Citations (Not Self Cited) = 91(Dec 10, 2025)

Location History:

Bridgewater, NJ (US) (2020)
Whippany, NY (US) (2022)
Whippany, NJ (US) (2012 - 2024)
Basking Ridge, NJ (US) (2023 - 2024)

Company Filing History:

13 out of 13

Amneal Complex Products Research LLC

patents

13 out of 22

Kashiv Biosciences, LLC

patents

10 out of 10

Kashiv Specialty Pharmaceuticals, LLC

Hoffmann-La Roche Inc.

7. 3 out of 834,350

Other

patents

where one patent can have more than one assignee

Years Active: 2012-2026

Loading Chart...

Areas of Expertise:

Extended Release

Gastroretentive

Osmotic Delivery

Chrono Drug Release

Pyridostigmine

Liothyronine

Trihexyphenidyl

Methylphenidate

Opioid Formulations

Abuse-Resistant

Sustained Release

Programmable Compositions

51 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12740951 - Delayed release compositions (2026-09-22),

2. 12233166 - Extended release compositions comprising pyridostigmine (2025-02-25),

3. 12042559 - Gastroretentive dosage forms for sustained drug delivery (2024-07-23),

4. 11964048 - Sustained release compositions comprising liothyronine (2024-04-23),

5. 11911515 - Extended release compositions comprising pyridostigmine (2024-02-27),

6. 11793747 - Self-regulating osmotic gastroretentive drug delivery systems (2023-10-24),

7. 11684580 - Extended release compositions comprising trihexyphenidyl (2023-06-27),

8. 11666536 - Extended release compositions comprising pyridostigmine (2023-06-06),

9. 11564888 - Extended release compositions comprising trihexyphenidyl (2023-01-31),

10. 11547670 - Delayed release methylphenidate compositions (2023-01-10),

11. 11478425 - Extended release compositions comprising pyridostigmine (2022-10-25),

12. 11464742 - Extended release compositions comprising trihexyphenidyl (2022-10-11),

13. 11439585 - Programmable pharmaceutical compositions for chrono drug release (2022-09-13),

14. 11419813 - Programmable pharmaceutical compositions for chrono drug release (2022-08-23),

15. 11318091 - Gastroretentive dosage forms for sustained drug delivery (2022-05-03),

Title: Inventor Dipen Desai

Introduction: Dipen Desai is a renowned inventor based in Whippany, New Jersey. He is known for his innovative contributions in various fields.

Latest Patents: Dipen Desai holds several patents in the areas of technology and healthcare, showcasing his diverse range of expertise.

Career Highlights: Throughout his career, Dipen Desai has been recognized for his groundbreaking inventions that have significantly impacted industries. His dedication to pushing the boundaries of innovation is evident in his patent portfolio.

Collaborations: Dipen Desai has collaborated with leading companies and research institutions to bring his inventions to life. His ability to work with diverse teams has led to successful outcomes in the development of new technologies.

Conclusion: In conclusion, Dipen Desai stands as a prominent figure in the world of innovation, with a track record of pioneering inventions that have made a lasting impact.